Yes, the lower counts could depend on Revlimid. In trials they evaluate the effect of Revlimid after 16 weeks - how long have you been taking the drug?
We know that about 25% of patients without the 5qdeletion will respond. There are no new studies about Revlimid in high risk MDS patients without the 5qdeletion - Revlimid is now always combined with other drugs. I have not seen a combination with Danazol but several with Vidaza and quite good results.